Opportunities in the Coronacrisis

To live in interesting times!

Peter Stevens joins us to talk about the market sell-off, how we're positioned, and interesting opportunities that we've found.

Also, available on iTunes and Spotify.  

Summary

0:24 – Peter wipes away his tears

0:50 – There’s growth and then there’s growth (e.g. Afterpay vs Zip)

1:30 – Why you should pay up for quality businesses

2:17 – Illiquidity during sell-offs

2:50 – Electro Optic Systems (ASX:EOS), a great business that does not fit ESG criteria

3:35 – Analysing quality within the WAAAX (the Australian equivalent of the FAANG)

4:54 – Frazis Capital’s avoidance of education and tourism stocks

7:40 – Theoretically maintaining a 20% cash position

8:00 – Michael discusses Ray Dalio’s “Principles”

9:25 – Carvana (NYSE:CVNA), Frazis Capital’s largest coronavirus casualty

10:22 – Afterpay’s (ASX:APT) accelerating growth and Frazis Capital’s internal forecasts

11:40 – Afterpay’s US in-store opportunity

12:30 – The benefits of an equities/treasuries strategy over popular options strategies

13:43 – Global stimulus packages and expansionary monetary policy

14:13 – Renewable energy businesses and how they may benefit from stimulus packages

14:45 – Twist Bioscience (NASDAQ:TWST), a well-performing Frazis Capital position

15:30 – Viruses tend to become less dangerous with time because of evolutionary pressures

16:55 – Gilead’s (NASDAQ:GILD) antiviral drug and the coronavirus

17:25 – Some Aussie smallcaps touting business expansion into virus-induced growth industries (e.g. hand sanitizers, diagnostics)

18:30 – The panic in supermarkets parallels the panic on markets

19:08 – “Buy when there is blood in the streets” (Baron Rothschild) and its relevance to this sell-off

19:25 – The origins of Rothschild’s famous blood in the streets quote

20:45 – Frazis Capital portfolio construction during the coronavirus sell-off

21:55 – Zoom’s (NASDAQ:ZM) coronavirus rally and its rich valuation

23:00 – Peloton (NASDAQ:PTON) and Carnival (NYSE:CCL), two stock picks from NYU Professor, Scott Galloway